Procentdelen af patienter, der rapporterede influenza- lignende symptomer, var størst ved den første injektion og faldt derefter med over 50% ved den anden injektion.
The percentage of patients reporting flu-like symptoms was greatest with the first injection and decreased by more than 50% with the second injection.